DONOR CHIMERISM IN PATIENTS WITH PRIMARY IMMUNODEFICIENCY AFTER ALLOGENEIC HEMATOPOIETIC STEM CELLS TRANSPLANTATION

DONOR CHIMERISM IN PATIENTS WITH PRIMARY IMMUNODEFICIENCY AFTER ALLOGENEIC HEMATOPOIETIC STEM CELLS TRANSPLANTATION

Allogeneic stem cell transplantation (alloHSCT) is effective curative option for a broad range of primary immunodeficiencies (PIDs). Hematopoietic chimerism monitoring in patients with various PIDs and its connection with the outcome of alloHSCT is of great interest. In this study 16 alloHSCT in pat...

Full description

Saved in:

Bibliographic Details
Main Authors:	V. A. Lavrinenko, Y. E. Marejco, E. Y. Berezovskaya, M. V. Stegantseva, N. V. Minakowskaja, M. V. Belevtsev
Format:	Article
Language:	Russian
Published:	ABV-press 2018-07-01
Series:	Онкогематология
Subjects:	chimerism white blood cell subpopulations primary immunodeficiency allogeneic stem cell transplantation graft-versus-host disease immune reconstitution children
Online Access:	https://oncohematology.abvpress.ru/ongm/article/view/292
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Regulatory T-cells and allogeneic hematopoietic stem cell transplantation
by: O. S. Karavaeva, et al.
Published: (2022-12-01)

Analysis of the results of allogeneic hematopoietic stem cell transplantation depending on HLA matching of the unrelated donor / recipient pair
by: Ye. V. Kuzmich, et al.
Published: (2015-01-01)

The late outcomes of syngeneic hematopoietic stem cell transplantation in patients with blood disorders
by: A. A. Dmitrova, et al.
Published: (2022-11-01)

Optimizing Timing and Preparation for Allogeneic Hematopoietic Stem Cell Transplantation in Higher-Risk Myelodysplastic Syndromes
by: Geng L, et al.
Published: (2025-08-01)

Pulmonary complications in children and adolescents after allogeneic hematopoietic stem cell transplantation
by: A. S. Frolova, et al.
Published: (2022-11-01)

Anti-monocyte globulin in allogeneic transplantation of hematopoietic stem cells
by: Yu. R. Zalyalov, et al.
Published: (2022-11-01)

Recommendations for (Pharmaco)Genetic Sampling in Patients Following Allogeneic Hematopoietic Stem Cell Transplantation
by: Anniek Bokma, et al.
Published: (2025-08-01)

Development of an ensemble prediction model for acute graft-versus-host disease in allogeneic transplantation based on machine learning
by: Lin Song, et al.
Published: (2025-07-01)

Risk factors of CMV replication after allogeneic hematopoietic stem cell transplantation in children and adolescents
by: S. N. Shiriaev, et al.
Published: (2014-09-01)

Treatment of refractory chronic graft-versus-host disease after allogeneic hematopoietic stem cell transplantation with low-dose interleukin-2
by: I. S. Moiseev, et al.
Published: (2015-12-01)

Major histocompatibility complex: history of discovery, evolution, structure, significance in transplantation of allogeneic hematopoietic stem cells
by: F. A. Omarova, et al.
Published: (2023-06-01)

Reduced morbidity and mortality of cGVHD in patients who received treatment with mesenchymal stromal cells for steroid-resistant aGVHD: long-term follow-up of a randomized phase 3 trial
by: Ke Zhao, et al.
Published: (2025-07-01)

Extracorporeal photopheresis in the treatment of graft-versus-host disease
by: I. V. Guz, et al.
Published: (2016-03-01)

Adoptitive immunotherapy with genetically engineered T lymphocytes modified to express chimeric antigen receptors
by: A. А. Pavlova, et al.
Published: (2017-04-01)

Allogeneic hematopoietic stem cells transplantation with reduced intensity conditioning regimen in children and adolescents with unfavorable forms of acute lymphoblastic leukemia
by: E. V. Semenova, et al.
Published: (2014-07-01)

Salvage therapy containing sorafenib and donor lymphocyte infusion is associated with improved outcomes for FLT3 wild-type acute myeloid leukemia relapsing after allogeneic hematopoietic stem cell transplantation
by: Zhonghui Jiang, et al.
Published: (2025-08-01)

Clinical Features of Cutaneous Acute Graft-versus-Host Disease after Allogeneic Hematopoietic Stem Cells Transplantation in Children with Hemato-Oncological Diseases
by: Tatiana S. Belysheva, et al.
Published: (2020-12-01)

The use of T-cells with chimeric antigen receptor (CAR-T) in combination with chemotherapy and radiotherapy for the treatment of solid tumors
by: M. R. Khaliulin, et al.
Published: (2024-04-01)

Preparation of Trop2-targeted chimeric antigen receptor T cells and study of their exhaustion status in vitro
by: LIU Xiuying, et al.
Published: (2025-08-01)

Proliferation and apoptosis of experimental animal’s lymphocytes after multiple transplantation of immune cells from opposite behavioral types of donors carried out in the juvenile period
by: E. V. Markova, et al.
Published: (2019-08-01)

Recent advances of chimeric antigen receptor T‐cell therapy for acute myeloid leukemia
by: Yang Liu, et al.
Published: (2025-05-01)

Current status of hematopoietic stem cell transplantation in Russia
by: L. P. Mendeleeva, et al.
Published: (2022-11-01)

Clinical Value of miR-3151 Overexpression in Synergistic Interaction with BAALC Host Gene in Patients with Acute Myeloid Leukemia after Allogeneic Hematopoietic Stem Cell Transplantation
by: AI Shakirova, et al.
Published: (2019-05-01)

Subpopulations of mobilized hematopoietic stem cells in patients with hematological malignances and donors: expression of CD38, HLA-DR and CD143
by: M. L. Kanaeva, et al.
Published: (2019-07-01)

The MICA‐129 dimorphism affects NKG2D signaling and outcome of hematopoietic stem cell transplantation
by: Antje Isernhagen, et al.
Published: (2015-10-01)

The microbiome in graft-versus-host disease: a tale of two ecosystems
by: Hamed Soleimani Samarkhazan, et al.
Published: (2025-07-01)

Case Report: Successful treatment of steroid- and ruxolitinib-refractory gastrointestinal acute graft-versus-Host disease with anti-thymocyte globulin
by: Lulu Zhang, et al.
Published: (2025-07-01)

Indications for transfusion of donor blood components in emergency surgery
by: E. N. Kobzeva, et al.
Published: (2018-08-01)

Creation of a patient-like model of esophageal cancer in immunodeficient mice
by: S. O. Kit, et al.
Published: (2020-04-01)

Significance of kidney and spleen volumes analyzed via three-dimensional computed tomography prior to allogeneic stem cell transplantation
by: Shota Nono, et al.
Published: (2025-07-01)

The Predictive Value of Absolute Lymphocyte Count and T Cell Subpopulations for Sepsis Prognosis
by: Jia X, et al.
Published: (2024-11-01)

Prurigo Nodularis in a Patient With Primary B‐Cell Immunodeficiency Successfully Treated With Low‐Dose Methotrexate: A Case Report
by: Hamad El Hajj, et al.
Published: (2025-07-01)

Chimeric Antibody 14D5 Protects Mice against the Far-Eastern, Siberian, and European Tick-borne Encephalitis Virus
by: Andrey L. Matveev, et al.
Published: (2019-04-01)

DONOR’S BONE MARROW CELLS AS REGULATORS OF IMMUNE TOLERANCE INDUCTION IN RECIPIENT’S OF ALLOGENIC ORGANS
by: N. A. Onishchenko, et al.
Published: (2009-06-01)

Late non-infectious lung damage in children after allogeneic hematopoietic stem cells transplantation
by: Yu. V. Skvortsova, et al.
Published: (2015-06-01)

Risk factors of cytomegalovirus infection in patients after allogeneic hematopoietic stem cells transplantation
by: D. N. Balashov, et al.
Published: (2022-11-01)

Diverse potential of chimeric antigen receptor‐engineered cell therapy: Beyond cancer
by: Lvying Wu, et al.
Published: (2025-04-01)

The prevalence and nosological structures of primary immunodeficiencies among children in the Altai region
by: N. V. Shakhova, et al.
Published: (2023-07-01)

Generation of donor-specific immunotolerance in renal-allograft recipients
by: V. A. Goryainov, et al.
Published: (2018-08-01)

Human immunodeficiency virus and anaesthesia
by: M. Khalpey
Published: (2012-06-01)